These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 30635966)
1. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. Hu C; Zhao L; Duan J; Li L J Cell Mol Med; 2019 Mar; 23(3):1657-1670. PubMed ID: 30635966 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Kim MD; Kim SS; Cha HY; Jang SH; Chang DY; Kim W; Suh-Kim H; Lee JH Exp Mol Med; 2014 Aug; 46(8):e110. PubMed ID: 25145391 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis. Liu P; Qian Y; Liu X; Zhu X; Zhang X; Lv Y; Xiang J Front Immunol; 2022; 13():1096402. PubMed ID: 36685534 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease. Yuan M; Hu X; Yao L; Jiang Y; Li L Stem Cell Res Ther; 2022 May; 13(1):179. PubMed ID: 35505419 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S J Transl Med; 2013 Mar; 11():78. PubMed ID: 23531302 [TBL] [Abstract][Full Text] [Related]
15. Advantages of adipose tissue stem cells over CD34 De Luna-Saldivar MM; Marino-Martinez IA; Franco-Molina MA; Rivera-Morales LG; Alarcón-Galván G; Cordero-Pérez P; Rojas-Martínez A; Rodríguez-Padilla C; Muñoz-Espinosa LE Ann Hepatol; 2019; 18(4):620-626. PubMed ID: 31147180 [TBL] [Abstract][Full Text] [Related]
16. In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice. Yamaza T; Alatas FS; Yuniartha R; Yamaza H; Fujiyoshi JK; Yanagi Y; Yoshimaru K; Hayashida M; Matsuura T; Aijima R; Ihara K; Ohga S; Shi S; Nonaka K; Taguchi T Stem Cell Res Ther; 2015 Sep; 6(1):171. PubMed ID: 26358689 [TBL] [Abstract][Full Text] [Related]
17. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. Li Q; Zhou X; Shi Y; Li J; Zheng L; Cui L; Zhang J; Wang L; Han Z; Han Y; Fan D PLoS One; 2013; 8(4):e62363. PubMed ID: 23638052 [TBL] [Abstract][Full Text] [Related]
18. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Ren H; Zhao Q; Cheng T; Lu S; Chen Z; Meng L; Zhu X; Yang S; Xing W; Xiao Y; Ren Q; Chi Y; Gu D; Yang R; Han ZC Cytotherapy; 2010 May; 12(3):371-83. PubMed ID: 20184502 [TBL] [Abstract][Full Text] [Related]
19. Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway. Bi H; Ming L; Cheng R; Luo H; Zhang Y; Jin Y J Tissue Eng Regen Med; 2017 Oct; 11(10):2685-2698. PubMed ID: 27430962 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model. Wang X; Wang H; Lu J; Feng Z; Liu Z; Song H; Wang H; Zhou Y; Xu J Tissue Eng Regen Med; 2020 Oct; 17(5):683-693. PubMed ID: 32621283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]